Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Authors: Omid Hamid, Igor Puzanov, Reinhard Dummer, Jacob Schachter, Adil Daud, Dirk Schadendorf, Christian U. Blank, Lee D. Cranmer, Caroline Robert, Anna C. Pavlick, René González, F. Stephen Hodi, Paolo A. Ascierto, April K.S. Salama, Kim Margolin, Tara C. Gangadhar, Ziwen Wei, Scot Ebbinghaus, Nageatte Ibrahim, Antoni Ribas - European Journal of Cancer 2017 cited by 180